Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.CSCI
Alternate Symbol(s):
CSCI
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CSCI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Next
(2244)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 13, 2024 1:36pm
RE:RE:RE:New Press Release - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
This means cosciens SG&A is higher due to merged SG&A of 2 co.s. It does NOT mean it was a merger related expense.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Aug 13, 2024 1:10pm
RE:RE:New Press Release - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
News release: Operating Expenses Our total operating expenses for the three-month period ended June 30, 2024, was $4.5 million as compared with $1.9 million for the same period in 2023. This
...more
(2244)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 13, 2024 11:25am
RE:New Press Release - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
Lousy disclosure. Cash flow from ops in qtr was $3.2M burn but the bozos did not say how much was due to one-time expenses for merger.
(2244)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 13, 2024 10:56am
RE:RE:New Press Release - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
Ceapro revenues up from q1 24 after factoring in fx... Cdn Cdn
...more
(2244)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 13, 2024 10:45am
RE:RE:RE:New Press Release - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
Adjusting for Fx and removing Aeterna license fees & development services.... Cdn US
...more
(2244)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 13, 2024 10:13am
RE:RE:New Press Release - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
w-t-h? Ceapro revenue Aeterna revenue Total Cosciens
...more
(2244)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 13, 2024 9:21am
RE:New Press Release - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
Ceapro revs down vs q1 24. Gross profit impacted by merger? Revenues Gross profit Gross margin
...more
(2244)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 13, 2024 9:13am
RE:New Press Release - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
Cooked books. Last year Aeterna reported Q2 revenue of $2.246M, now it shows it as $1.392M
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 13, 2024 9:03am
"fulsome update shortly"
"fulsome update shortly." "We are also excited that we remain on track to obtain and announce in Q’3 2024 top-line data from our recently completed Phase 3 safety and efficacy study
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 13, 2024 8:05am
New Press Release - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
Data from pivotal DETECT-Trial evaluating macimorelin for the diagnosis of childhood-onset growth hormone deficiency expected in Q3 2024Company ended the quarter with US$27.8 million in cashTORONTO, ONTARIO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI...
read article.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 12, 2024 2:02pm
Linkedin comment
Matthew H. JohnsonMatthew H. Johnson • 3rd+ • 3rd+Talent Driven Workplace Advice | Data Driven Real Estate Solutions | National Science, Innovation & Nonprofit Practice LeadTalent Driven Workplace
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 12, 2024 12:03am
Macrophages and COVID
J Exp Med . 2024 Jun 3;221(6):e20232192. doi: 10.1084/jem.20232192.
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 11, 2024 9:54pm
Oct. 8, 2024: A novel approach for scalable production
Pressurized Gas eXpanded (PGX) liquid Technology: A novel approach for scalable production of biopolymer aerogels and composites. (614) Tue, October 08
...more
(167)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Comment by
Hopeforthebest
on Aug 11, 2024 5:53pm
RE:PGX Scale-up:
The original timeline for the 50l PGX scale up was the end of 2023 not 15 weeks ago in true gagnon he has never met an original self imposed timeline and who the hell knows when it will get done.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed
EnviroGold Global Announces Appointment of Chief Operating Officer